A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
All content for Decoded is the property of Dr. Jurgi Camblong and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
Rethinking Cancer Through AI and Precision Medicine with Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Center
Decoded
37 minutes
1 month ago
Rethinking Cancer Through AI and Precision Medicine with Dr. Pedram Razavi, Memorial Sloan Kettering Cancer Center
Cancer has been described for a long time, yet only now are we beginning to truly decode it. In this episode of Decoded, Dr. Jurgi Camblong, Founder of SOPHiA GENETICS, speaks with Dr. Pedram Razavi, Director of Liquid Biopsy and Cancer Genomics at Memorial Sloan Kettering Cancer Center. From the first historical mentions of tumors to today’s breakthroughs in precision oncology, Dr. Razavi shares how genomics, liquid biopsy, and AI are reshaping the way we detect, treat, and even thin...
Decoded
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
